P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer

Shariat, S. and Badiee, A. and Jalali, S. A. and Mansourian, M. and Yazdani, M. and Mortazavi, S. A. and Jaafari, M. R. (2014) P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer. Cancer Letters, 355 (1). pp. 54-60.

[img] Other (Article)
S030438351400528X

Download (67kB)
Item Type: Article
Additional Information: Cited By :40 Export Date: 7 July 2020
Subjects: WP Gynecology
QV pharmacology
QZ pathology-neoplasms-Genetics
Divisions: Mashhad University of Medical Sciences
Depositing User: mr lib5 lib5
Date Deposited: 26 Jul 2020 09:26
Last Modified: 26 Jul 2020 09:26
URI: http://eprints.mums.ac.ir/id/eprint/22600

Actions (login required)

View Item View Item